Filing Details
- Accession Number:
- 0000911916-16-000600
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-30 16:32:58
- Reporting Period:
- 2016-06-30
- Filing Date:
- 2016-06-30
- Accepted Time:
- 2016-06-30 16:32:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1348649 | Colucid Pharmaceuticals Inc. | CLCD | Pharmaceutical Preparations (2834) | 203419541 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1658550 | Raymond Skwierczynski | C/O Colucid Pharmaceuticals, Inc. 222 Third Street Cambridge MA 02142 | Head,Pharmaceutical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-06-30 | 516 | $7.01 | 2,737 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Skwierczynski on June 1, 2016.
- Represents the sale of 516 shares in multiple transactions, ranging in price from $7.00 to $7.71 per share, resulting in a weighted average sale price of $7.011. The reporting person will provide, upon request bythe SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
Billionaire Hedge Funds
